-
Most Popular
Search Results
240 results for etp
AMAT Stock Earnings: Applied Mat Beats EPS, Beats Revenue for Q3 2024
AMAT stock results show that Applied Mat beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.
DESP Stock Earnings: Despegar.com Beats EPS, Beats Revenue for Q2 2024
DESP stock results show that Despegar.com beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Wedbush Just Raised its Price Target on These 7 Stocks: August 12, 2024
New Wedbush price targets have been issued for each of the following seven stocks, including a few that may come as a surprise to some.
3 Infrastructure Stocks to Put on Your Buy List Now
Here are three infrastructure stocks to keep on your buy list in 2024. Jump on the opportunity before they take off.
SWKH Stock Earnings: SWK Holdings Beats EPS, Beats Revenue for Q2 2024
SWKH stock results show that SWK Holdings beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
HUGE Stock Earnings: FSD Pharma Misses EPS for Q2 2024
HUGE stock results show that FSD Pharma missed analyst estimates for earnings per share the second quarter of 2024.
ACHL Stock Earnings: Achilles Therapeutics Meets EPS for Q2 2024
ACHL stock results show that Achilles Therapeutics met analyst estimates for earnings per share the second quarter of 2024.
VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q2 2024
VIRX stock results show that Viracta Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
UNCY Stock Earnings: Unicycive Therapeutics Beats EPS for Q2 2024
UNCY stock results show that Unicycive Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
COCP Stock Earnings: Cocrystal Pharma Misses EPS for Q2 2024
COCP stock results show that Cocrystal Pharma missed analyst estimates for earnings per share the second quarter of 2024.
SGMT Stock Earnings: Sagimet Biosciences Beats EPS for Q2 2024
SGMT stock results show that Sagimet Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
RVPH Stock Earnings: Reviva Pharmaceuticals Beats EPS for Q2 2024
RVPH stock results show that Reviva Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.
FFIE Stock Earnings: Faraday Future Beats EPS, Misses Revenue for Q1 2024
FFIE stock results show that Faraday Future beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
SPCB Stock Earnings: SuperCom Beats EPS, Beats Revenue for Q2 2024
SPCB stock results show that SuperCom beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
SA Stock Earnings: Seabridge Gold Beats EPS for Q2 2024
SA stock results show that Seabridge Gold beat analyst estimates for earnings per share the second quarter of 2024.
TCON Stock Earnings: TRACON Pharma Beats EPS for Q2 2024
TCON stock results show that TRACON Pharma beat analyst estimates for earnings per share the second quarter of 2024.
PBLA Stock Earnings: Panbela Therapeutics Beats EPS for Q2 2024
PBLA stock results show that Panbela Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
MODD Stock Earnings: Modular Medical Beats EPS for Q1 2025
MODD stock results show that Modular Medical beat analyst estimates for earnings per share the first quarter of 2025.
MBRX Stock Earnings: Moleculin Biotech Beats EPS for Q2 2024
MBRX stock results show that Moleculin Biotech beat analyst estimates for earnings per share the second quarter of 2024.
BORR Stock Earnings: Borr Drilling Misses EPS, Beats Revenue for Q2 2024
BORR stock results show that Borr Drilling missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q2 2024
ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
PYPD Stock Earnings: PolyPid Beats EPS for Q2 2024
PYPD stock results show that PolyPid beat analyst estimates for earnings per share the second quarter of 2024.
OTLK Stock Earnings: Outlook Therapeutics Beats EPS for Q3 2024
OTLK stock results show that Outlook Therapeutics beat analyst estimates for earnings per share the third quarter of 2024.
10 – 10 of 240 results
